Novo Nordisk board looking for new CEO
Tel Aviv
NOVO Nordisk's board is working to find a replacement for chief executive officer Lars Rebien Soerensen, who led the Danish company to one of the best stock market performances of any drugmaker over the past 14 years.
Mr Rebien Soerensen, 60, is unlikely to remain in the job through the end of his contract in 2019, and will step down from Scandinavia's biggest company by market value as soon as a new leader has been identified, Dani…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Sanofi Q1 profit slips on generic competition, forex effects
Toyota hits record annual output, sales on robust demand
Latest Singapore 6-month T-bill offering cut-off yield of 3.74% as applications dip
Suntec Reit Q1 DPU down 13% to S$0.01511 in absence of capital distribution
Nissan, Mazda roll out new models for China as they aim for comeback
South Korea readies new system to detect illegal short-selling